Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
![]() |
World Community Grid Forums
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
No member browsing this thread |
Thread Status: Active Total posts in this thread: 1122
|
![]() |
Author |
|
Dan60
Senior Cruncher Brazil Joined: Mar 29, 2006 Post Count: 185 Status: Offline Project Badges: ![]() ![]() ![]() ![]() |
Genetic marker may predict heart disease risk in people with HIV
"The group also found that two polymorphisms – SDF1-3`A and CX3CR-1 249I – associated with inflammatory chemokines implicated in the development of atherosclerosis, protected against progression of atherosclerosis (Coll 2007)." the complete article here |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Sunday, January 31, 2010
Study Finds New Vaccine Effective in Preventing TB in African Patients With HIV Infection ![]() |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Synthesis of New Thienyl Ring Containing HIV-1 Protease Inhibitors: Promising Preliminary Pharmacological Evaluation against Recombinant HIV-1 Proteases
http://pubs.acs.org/doi/abs/10.1021/jm900846f A series of new thienyl ring containing analogues of nelfinavir and saquinavir with different substitution patterns were synthesized from suitable enantiopure diols. Their inhibitory activity against wild type recombinant HIV-1 protease was evaluated. In general thienyl groups spaced from the core by a methylene group gave products showing IC50 in the nanomolar range, irrespective of the type and the substitution pattern of the heterocycle. The range of activity of the two most active compounds is substantially maintained or even increased against two commonly selected mutants, under drug pressure, such as V32I and V82A. |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
5-Modified-2′-dU and 2′-dC as Mutagenic Anti HIV-1 Proliferation Agents: Synthesis and Activity
http://pubs.acs.org/doi/abs/10.1021/jm901758f With the goal of limiting HIV-1 proliferation by increasing the mutation rate of the viral genome, we synthesized a series of pyrimidine nucleoside analogues modified in position 5 of the aglycone moiety but unmodified on the sugar part. The synthetic strategies allow us to prepare the targeted compounds directly from commercially available nucleosides. All compounds were tested for their ability to reduce HIV-1 proliferation in cell culture. Two of them (5-hydroxymethyl-2′-dU (1c) and 5-hydroxymethyl-2′-dC (2c)) displayed a moderate antiviral activity in single passage experiments. The same two compounds plus two additional ones (5-carbamoyl-2′-dU (1a) and 5-carbamoylmethyl-2′-dU (1b)) were potent inhibitors of HIV-1 RT activity in serial passage assays, in which they induced a progressive loss of HIV-1 replication. In addition, viruses collected after seven passages in the presence of 1c and 2c replicated very poorly after withdrawal of these compounds, consistent with the accumulation of deleterious mutations in the HIV-1 genome. |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
Dan60
Senior Cruncher Brazil Joined: Mar 29, 2006 Post Count: 185 Status: Offline Project Badges: ![]() ![]() ![]() ![]() |
Scientists Make Breakthrough in HIV Drug Research
"British and U.S. researchers said they had grown a crystal that enabled them to see the structure of an enzyme called integrase, which is found in retroviruses like HIV and is a target for some of the newest HIV medicines... When the human immunodeficiency virus (HIV) infects someone, it uses the integrase enzyme to paste a copy of its genetic information into their DNA, Cherepanov explained in the study published in the Nature journal on Sunday. Some new drugs for HIV -- like Isentress from Merck & Co (MRK.N) and elvitegravir, an experimental drug from Gilead Sciences (GILD.O) -- work by blocking integrase, but scientists are not clear exactly how they work or how to improve them. The only way to find out was to obtain high-quality crystals -- a project that had defeated scientists for many years." the whole article here |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Dan60 Kindly read the posts carefully ![]() |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Compound found that targets wide range of viruses
Cell-culture and animal tests show antiviral could provide protection against HIV, Ebola, hepatitis C, herpes and more |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Discovery May Lead To New Class Of AIDS Drugs
http://www.kpbs.org/news/2010/feb/04/discovery-may-lead-new-class-aids-drugs/ Scrripps researcher Alex Perryman said the compounds have yet to show they inhibit the virus. But they may become anchor points for the development of new drugs that attack drug resistant HIV. |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
|
||
|
|
![]() |